Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2008
08/07/2008WO2008092876A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
08/07/2008WO2008092874A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
08/07/2008WO2008092873A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
08/07/2008WO2008092872A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
08/07/2008WO2008092786A1 6-oxo-6,7-dihydro-5h-dibenzo[b,d]azepin-7-yl derivatives
08/07/2008WO2008092785A1 Novel 2-aminooxazolines as taar1 ligands for cns disorders
08/07/2008WO2008092666A1 Aryl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
08/07/2008WO2008092665A1 Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
08/07/2008WO2008092591A2 Use of guanidinoacetic acid (salts) combined with betaine and/or choline for producing a health-promoting agent
08/07/2008WO2008092292A1 Isoquinolone compounds as subtype-selective agonists for melatonin receptors mt1 and mt2
08/07/2008WO2008070277A3 Methods for treating disruptive behavior disorders
08/07/2008WO2008069960A3 Separable solid dosage form administration system
08/07/2008WO2008054748A3 Indazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
08/07/2008WO2008053301A3 Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
08/07/2008WO2008036642A3 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
08/07/2008WO2008035177A3 Combination of mt1 and mt2 melatonin receptor agonists and a norepinephrine/dopamine reuptake inhibitor
08/07/2008WO2007140222A3 Pyrrolopyrimidine compounds and their uses
08/07/2008WO2007137181A3 Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation
08/07/2008WO2007091947A8 Novel spiro[imidazolidine-4,3'-indole]-2,2',5(1'h)-triones for treatment of conditions associated with vanilloid receptor 1
08/07/2008US20080188567 Crystalline polymorphs of desvenlafaxine succinate and their preparations
08/07/2008US20080188557 Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof
08/07/2008US20080188543 {1-Methyl-6-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid; deep vein thrombosis and coronary heart disease, Alzheimer's disease and pulmonary fibrosis
08/07/2008US20080188542 Novel indole polymorphs
08/07/2008US20080188540 Pharmaceutical compositions containing substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
08/07/2008US20080188537 Method of treating bipolar depression with a benzamide derivative
08/07/2008US20080188531 Ethyl 2'-(acetylamino)-4'-methyl-4,5'-bi-1,3-thiazole-2-carboxylate; autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial, viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries
08/07/2008US20080188528 Modulators of C3a receptor and methods of use thereof
08/07/2008US20080188526 Pharmaceutical composition comprising, in combination, saredutant and escitalopram
08/07/2008US20080188525 Rolipram or methylphenyl substituted rolipram; Cognitive dysfunction; administering a (PDE4) inhibitor in the absence of formal cognitive training
08/07/2008US20080188524 Administering a cyclin-dependent kinase (CDK) inhibitor; for example, N-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl)methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide
08/07/2008US20080188523 S)-(-)-N-[4-(4-acetamido-4-phenylpiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide; significantly enhancing the pharmacological effects of each of the compounds used alone, in particular the antidepressant effects
08/07/2008US20080188520 e.g. 1-(2-Cyclopropylmethoxy-1,2-diphenylethyl)-1H-pyridin-2-one; potassium (K+) channel-blocking agent; potassium channel KACh and TASK-1 channel blocking agent; atrial arrhythmias, atrial fibrillation or atrial flutter; respiratory disorders, neurodegenerative disorders; anticarcinogenic agent
08/07/2008US20080188519 Novel azacyclic ethynyl derivatives
08/07/2008US20080188518 5-Substituted Imidazoles
08/07/2008US20080188514 e.g. 5-(3-methoxybenzyloxy)-1H-pyrrolo[2,3-b]pyridine; protein kinases inhibitor; central nervous system disorders; Alzheimer's disease; Parkinson's disease; anticancer, antitumor agents; analgesics; cogestive heart failure; skin disorders; inflammatory bowel disorders; transplant rejection
08/07/2008US20080188510 Novel methods using zonisamide
08/07/2008US20080188509 Transdermal Preparations and Method for Relieving Side Effects in Pergolide Therapy
08/07/2008US20080188503 New Compounds II
08/07/2008US20080188502 New Compounds I
08/07/2008US20080188501 retrovirus inhibor; anticarcinogenic, antidiabetic agent, immunosuppressant, autoimmune diseases; 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-4-fluoro-benzonitrile; type 2 diabetes mellitus, impaired glucose tolerance, obesity, multiple sclerosis
08/07/2008US20080188495 e.g. 6-[(1E)-2-(3,4-dimethoxyphenyl)vinyl]-3-ethyl-1,5-dimethyl-1,3-dihydrothiopheno[2,3-d]pyrimidine-2,4-dione; neurodegenerative disorders, antiischemic agent, antidepressant, attention deficit disorder, hepatic fibrosis, cirrhosis of the liver, and drug addiction
08/07/2008US20080188492 Organic Compounds
08/07/2008US20080188490 e.g. 1-(3-Chloro-phenylethynyl)-3-(3,4-difluoro-phenylamino)-cyclohexanol; metabotropic glutamate receptors modulator/antagonist;
08/07/2008US20080188478 Compounds Useful In Therapy
08/07/2008US20080188477 Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them
08/07/2008US20080188473 Indoles Useful in the Treatment of Inflammation
08/07/2008US20080188465 Stable pure anhydrous polymorphic Form I, free of other polymorphs and solvating agents such as water and organic solvents; anti-psychotic agent
08/07/2008US20080188464 Combinations of Dopamine D2 Receptor Blockade with Norepinephrine Reuptake Inhibition and With Norepinephrine Alpha 2 Receptor Blockade
08/07/2008US20080188461 Compositions and methods for detecting, preventing and treating seizures and seizure related disorders
08/07/2008US20080188457 Modulation of Neurogenesis with Biguanides and GSK3-beta Agents
08/07/2008US20080188452 Macrocyclic Benzofused Pyrimidine Derivatives
08/07/2008US20080188443 (4 beta S,7R,8 alpha R)-4 beta -benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-7-(trifluoromethyl)-4b,5,6,7,8,8 alpha ,9,10-octahydrophenanthrene-2-carboxamide; modulators of the glucocorticoid receptor; asthma, dermatitis, inflammatory bowel disease, Alzheimer's disease, psychotic major depression
08/07/2008US20080188438 Oligonucleotide molecule that interferes with the Fra-1/VEGF-D promoter or the Fra-1/c-Jun interaction to a subject suffering from a brain cancer
08/07/2008US20080188435 Methods of dignosing or treating depression on basis of increased cerebrospinal fluid levels of neurotrodhin 3
08/07/2008US20080188426 Sodium dependent glucose transporter inhibition; hyperglycemia associated diseases; 3-glucopyranosyloxy- 1H-indazole and 1H-pyrazolo[3,4-b]pyridine derivatives
08/07/2008US20080188425 Dihydroouabain-like factor and diagnostic & therapeutic compositions and methods
08/07/2008US20080188423 Pi-3 kinase inhibitor prodrugs
08/07/2008US20080188417 Beta-like glycoprotein hormone polypeptide and heterodimer
08/07/2008US20080188408 Protein and Preventive/Remedy for Neurodegenerative Diseases Such as Polyglutamine Diseases by Utilizing the Same
08/07/2008US20080188402 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
08/07/2008US20080187961 Polynucleotides encoding signal peptide-containing molecules
08/07/2008US20080187605 Preventing pathological nerve cell suicide (neuroapoptosis) in immature nervous systems
08/07/2008US20080187590 Containing entacapone; therapy for parkinson's disease
08/07/2008US20080187587 Multilayer capsules for sustained release ; therapy for sleep disorders
08/07/2008US20080187575 Pyrimidine Derivatives
08/07/2008US20080187573 Pharmaceutical composition formulated for pre-gastric absorption of monoamine oxidase b inhibitor component
08/07/2008US20080187521 Use Of Medulliadrenal Chromaffin Cells Or Peptide Functional Cells
08/07/2008US20080187510 Methods for Improving Drug Disposition
08/07/2008US20080187492 Determining whether a compound, an inhibitor of a glutamate receptor, reduces Fragile X syndrome, a tauopathy, Huntington's disease, neurofibromatosis 1, Parkinson's disease of an analogous disease in a Drosophila
08/07/2008DE202007018474U1 Kirstallformen von 9-Hydroxy-Risperidon (Paliperidon) Kirstallformen of 9-hydroxy-risperidone (paliperidone)
08/07/2008DE202007018473U1 9-Hydroxy-Risperidon (Paliperidon) 9-hydroxy-risperidone (paliperidone)
08/07/2008DE102007005045A1 New phenothiazine derivative for use in preparing medicine for blood sugar lowering and for treatment of diabetes, nicotine dependence, alcohol dependence, central nervous system disorders, schizophrenia, and Alzheimer's disease
08/07/2008DE102007004781A1 Verwendung von Guanidinoessigsäure(-Salzen) zur Herstellung eines gesundheitsfördernden Mittels The use of guanidinoacetic acid (salts) for the preparation of a beneficial agent
08/07/2008CA2678391A1 Dosage regimen for comt inhibitors
08/07/2008CA2677205A1 Topiramate plus naltrexone for the treatment of addictive disorders
08/07/2008CA2677096A1 Kinase inhibitors
08/07/2008CA2676167A1 Substituted pyrano[2,3-b]pyridine derivatives as cannabinoid-1 receptor modulators
08/07/2008CA2676160A1 6-oxo-6,7-dihydro-5h-dibenzo[b,d]azepin-7-yl derivatives
08/07/2008CA2675468A1 Aryl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
08/07/2008CA2675466A1 Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
08/07/2008CA2675221A1 Novel 2-aminooxazolines as taar1 ligands
08/07/2008CA2672808A1 Process for the preparation of o-desmethyl venlafaxine
08/07/2008CA2669563A1 Agent for treatment of multiple sclerosis
08/06/2008EP1953165A1 Aza-substituted spiro derivative
08/06/2008EP1953160A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as CRF antagonists
08/06/2008EP1953159A1 6-Benzyl-2,3,4,7-tetrahydro-indolo[2,3-c]quinoline compounds useful as PDE5 inhibitors
08/06/2008EP1953158A1 Bicyclic cinnamide compound
08/06/2008EP1953157A1 New crystal form of cabergoline
08/06/2008EP1953154A1 Morpholine type cinnamide compound
08/06/2008EP1953153A1 Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
08/06/2008EP1953151A1 Salts of cynnamide compound or solvates thereof
08/06/2008EP1953141A1 Aryl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
08/06/2008EP1953136A1 Derivatives of (-)-venlafaxine and methods of preparing and using the same
08/06/2008EP1952824A1 Compositions and methods of treatment using L-type calcium channel blockers and cholinesterase inhibitors
08/06/2008EP1952814A1 Therapeutic agent comprising glycolipid derivative capable of inhibiting the function of nkt cell as active ingredient
08/06/2008EP1951750A2 Modulation of angiogenesis by a-beta peptide fragments
08/06/2008EP1951727A1 Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists
08/06/2008EP1951725A1 N-sulfamoyl-n -benzopyranpiperidines as inhbitors of carbonic anhydrases
08/06/2008EP1951720A1 8-[bis-(2-chloro-phenyl)-methyl]-3-phenyl-8-aza-bicyclo [3.2.1]octane-3-carboxylic acid amide as ligand for the nociceptin receptor orl-1
08/06/2008EP1951718A1 4-oxadiazolyl-piperidine compounds and use thereof
1 ... 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 ... 1833